Cationic PEGylated liposomes incorporating an antimicrobial peptide tilapia hepcidin 2–3: an adjuvant of epirubicin to overcome multidrug resistance in cervical cancer cells
Vivian Juang,1 Hsin-Pin Lee,2 Anya Maan-Yuh Lin,1,3 Yu-Li Lo1 1Department and Institute of Pharmacology, National Yang-Ming University, 2Department of Biological Sciences and Technology, National University of Tainan, 3Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan...
Guardado en:
Autores principales: | Juang V, Lee HP, Lin AMY, Lo YL |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bc6d1f1439b7435593098003aa96e804 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma
por: Ju RJ, et al.
Publicado: (2016) -
Sensitive and Selective Electrochemical Detection of Epirubicin as Anticancer Drug Based on Nickel Ferrite Decorated with Gold Nanoparticles
por: Mohammad Mehmandoust, et al.
Publicado: (2021) -
Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance
por: Haghiralsadat F, et al.
Publicado: (2018) -
In vitro anticancer activity and oxidative molecular damage by cannabidiol administered alone and in combination with epirubicin
por: Margarita Zhelyazkova, et al.
Publicado: (2021) -
Application of multifunctional targeting epirubicin liposomes in the treatment of non-small-cell lung cancer
por: Song X, et al.
Publicado: (2017)